Risk of bronchopulmonary dysplasia by second-trimester maternal serum levels of α-fetoprotein, human chorionic gonadotropin, and unconjugated estriol

Pediatric Research

Volumn 71, Issue 4, 2012, Pages 399-406

  Jelliffe Pawlowski, Laura L ^a   Shaw, Gary M ^b   Stevenson, David K ^b   Oehlert, John W ^b   Quaintance, Cele ^b   Santos, Allan J ^b   Baer, Rebecca J ^a   Currier, Robert J ^a   O'Brodovich, Hugh M ^a   Gould, Jeffrey B ^b  

^a CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; ESTRIOL;

ADULT; ARTICLE; FEMALE; HUMAN; LUNG DYSPLASIA; MATERNAL SERUM; POPULATION RESEARCH; PRENATAL PERIOD; PRIORITY JOURNAL; RISK FACTOR; SECOND TRIMESTER PREGNANCY;

ADOLESCENT; ADULT; ALPHA-FETOPROTEINS; BIOLOGICAL MARKERS; BRONCHOPULMONARY DYSPLASIA; CHORIONIC GONADOTROPIN; ESTRIOL; FEMALE; HUMANS; INFANT, NEWBORN; INFLAMMATION; PREGNANCY; PREGNANCY TRIMESTER, SECOND; REGRESSION ANALYSIS; RISK;

EID: 84857934462     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2011.73     Document Type: Article

References (49)

1. Northway WH Jr, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med 1967;276:357-68.
2. Husain AN, Siddiqui NH, Stocker JT. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol 1998;29:710-7. (Pubitemid 28322056)
3. Deakins KM. Bronchopulmonary dysplasia. Respir Care 2009;54:1252-62.
4. Baraldi E, Filippone M. Chronic lung disease after premature birth. N Engl J Med 2007;357:1946-55. (Pubitemid 350074689)
5. Kramer BW, Kallapur S, Newnham J, Jobe AH. Prenatal inflammation and lung development. Semin Fetal Neonatal Med 2009;14:2-7.
6. Bose C, Laughon M, Allred EN, et al.; Elgan Study Investigators. Blood protein concentrations in the first two postnatal weeks that predict bronchopulmonary dysplasia among infants born before the 28th week of gestation. Pediatr Res 2011;69:347-53.
7. Baier RJ, Majid A, Parupia H, Loggins J, Kruger TE. CC chemokine concentrations increase in respiratory distress syndrome and correlate with development of bronchopulmonary dysplasia. Pediatr Pulmonol 2004;37:137-48. (Pubitemid 38120984)
8. Jasson B, Tullus K, Brauner A, Lu Y, Noack G. Early increase of TNF α and IL-6 in tracheobronchial aspirate fluid indicator of subsequent chronic lung disease in preterm infants. Arch Dis Child Fetal Neonatal Ed 1997;77:F198-201. (Pubitemid 28201584)
9. Ramsay PL, DeMayo FJ, Hegemier SE, Wearden ME, Smith CV, Welty SE. Clara cell secretory protein oxidation and expression in premature infants who develop bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;164:155-61. (Pubitemid 33151313)
10. Beresford MW, Shaw NJ. Detectable IL-8 and IL-10 in bronchoalveolar lavage fluid from preterm infants ventilated for respiratory distress syndrome. Pediatr Res 2002;52:973-8. (Pubitemid 35379481)
11. Yoon BH, Romero R, Jun JK, et al. Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-α, interleukin-1 β, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 1997;177:825-30. (Pubitemid 27516049)
12. Kim BI, Lee HE, Choi CW, et al. Increase in cord blood soluble E-selectin and tracheal aspirate neutrophils at birth and the development of new bronchopulmonary dysplasia. J Perinat Med 2004;32:282-7. (Pubitemid 38737538)
13. Ambalavanan N, Carlo WA, D'Angio CT, et al.; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Cytokines associated with bronchopulmonary dysplasia or death in extremely low birth weight infants. Pediatrics 2009;123:1132-41.
14. Velten M, Heyob KM, Rogers LK, Welty SE. Deficits in lung alveolarization and function after systemic maternal inflammation and neonatal hyperoxia exposure. J Appl Physiol 2010;108:1347-56.
15. Yamashita T, Nakane A, Watanabe T, Miyoshi I, Kasai N. Evidence that α-fetoprotein suppresses the immunological function in transgenic mice. Biochem Biophys Res Commun 1994;201:1154-59.
16. Filella X, Molina R, Alcover J, Coca F, Zarco MA, Ballesta AM. Influence of AFP, CEA and PSA on the in vitro production of cytokines. Tumour Biol 2001;22:67-71. (Pubitemid 32008962)
17. Potapovich AI, Pastore S, Kostyuk VA, et al. α-Fetoprotein as a modulator of the pro-inflammatory response of human keratinocytes. Br J Pharmacol 2009;158:1236-47.
18. van der Zee M, Dik WA, Kap YS, et al. Synthetic human chorionic gonadotropin-related oligopeptides impair early innate immune responses to Listeria monocytogenes in mice. J Infect Dis 2010;201:1072-80.
19. Marshall I, Ugrasbul F, Manginello F, et al. Congenital hypopituitarism as a cause of undetectable estriol levels in the maternal triple-marker screen. J Clin Endocrinol Metab 2003;88:4144-8. (Pubitemid 37153712)
20. Harel S, Tomer A, Barak Y, Binderman I, Yavin E. The cephalization index: a screening device for brain maturity and vulnerability in normal and intrauterine growth retarded newborns. Brain Dev 1985;7:580-4. (Pubitemid 16125795)
21. Jelliffe-Pawlowski LL, Baer RJ, Currier RJ. Second trimester serum predictors of preterm birth in a population-based sample of low-risk pregnancies. Prenat Diagn 2010;30:727-33.
22. Yaron Y, Cherry M, Kramer RL, et al. Second-trimester maternal serum marker screening: maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome. Am J Obstet Gynecol 1999;181:968-74. (Pubitemid 29503625)
23. Dugoff L, Hobbins JC, Malone FD, et al; FASTER Trial Research Consortium. Quad screen as a predictor of adverse pregnancy outcome. Obstet Gynecol 2005;106:260-7. (Pubitemid 41023261)
24. Cole LA. Biological functions of hCG and hCG-related molecules. Reprod Biol Endocrinol 2010;8:102.
25. Mizejewski GJ. Biological roles of α-fetoprotein during pregnancy and perinatal development. Exp Biol Med (Maywood) 2004;229:439-63. (Pubitemid 38736314)
26. Mizejewski GJ. Physiology of α-fetoprotein as a biomarker for perinatal distress: relevance to adverse pregnancy outcome. Exp Biol Med (Maywood) 2007;232:993-1004. (Pubitemid 47358183)
27. Handschuh K, Guibourdenche J, Tsatsaris V, et al. Human chorionic gonadotropin produced by the invasive trophoblast but not the villous trophoblast promotes cell invasion and is down-regulated by peroxisome proliferator-activated receptor-γ. Endocrinology 2007; 148:5011-9. (Pubitemid 47481552)
28. Zbella EA, Ilekis J, Scommegna A, Benveniste R. Competitive studies with dehydroepiandrosterone sulfate and 16 α-hydroxydehydroepiandrosterone sulfate in cultured human choriocarcinoma JEG-3 cells: effect on estrone, 17 β-estradiol, and estriol secretion. J Clin Endocrinol Metab 1986;63:751-7. (Pubitemid 16050581)
29. Khorram O, Vu L, Yen SS. Activation of immune function by dehydroepiandrosterone (DHEA) in age-advanced men. J Gerontol A Biol Sci Med Sci 1997;52:M1-7. (Pubitemid 27034824)
30. Mitchell JB, Dugas JP, McFarlin BK, Nelson MJ. Effect of exercise, heat stress, and hydration on immune cell number and function. Med Sci Sports Exerc 2002;34:1941-50. (Pubitemid 35440414)
31. Buhimschi CS, Turan OM, Funai EF, et al. Fetal adrenal gland volume and cortisol/dehydroepiandrosterone sulfate ratio in inflammation-associated preterm birth. Obstet Gynecol 2008;111:715-22. (Pubitemid 351654078)
32. Rerg L, Grahn M, Hasselquist D, Svensson E. On the adaptive significance of stress-induced immunosuppression. Proc Biol Sci 1998;265:1637-41. (Pubitemid 28442086)
33. van der Vaart H, Postma DS, Timens W, ten Hacken NH. Acute effects of cigarette smoke on inflammation and oxidative stress: a review. Thorax 2004;59:713-21. (Pubitemid 39061538)
34. Verlohren S, Muller DN, Luft FC, Dechend R. Immunology in hypertension, preeclampsia, and target-organ damage. Hypertension 2009;54:439-43.
35. Cheah FC, Jobe AH, Moss TJ, Newnham JP, Kallapur SG. Oxidative stress in fetal lambs exposed to intra-amniotic endotoxin in a chorioamnionitis model. Pediatr Res 2008;63:274-9. (Pubitemid 351301456)
36. De Luca G, Olivieri F, Melotti G, Aiello G, Lubrano L, Boner AL. Fetal and early postnatal life roots of asthma. J Matern Fetal Neonatal Med 2010;23:Suppl 3:80-3.
37. Miller JD, Benjamin JT, Kelly DR, Frank DB, Prince LS. Chorioamnionitis stimulates angiogenesis in saccular stage fetal lungs via CC chemokines. Am J Physiol Lung Cell Mol Physiol 2010;298:L637-45.
38. Leineweber K, Heusch G. β1-and β2-Adrenoceptor polymorphisms and cardiovascular diseases. Br J Pharmacol 2009;158:61-9.
39. Hadi HA. Fetal cerebral maturation in hypertensive disorders of pregnancy. Obstet Gynecol 1984;63:214-9. (Pubitemid 14177256)
40. Miller BA, Perez RS, Shah AR, Gonzales ER, Park TS, Gidday JM. Cerebral protection by hypoxic preconditioning in a murine model of focal ischemia-reperfusion. Neuroreport 2001;12:1663-9. (Pubitemid 32521483)
41. Ancel PY, Marret S, Larroque B, et al.; Epipage Study Group. Are maternal hypertension and small-for-gestational age risk factors for severe intraventricular hemorrhage and cystic periventricular leukomalacia? Results of the EPIPAGE cohort study. Am J Obstet Gynecol 2005;193:178-84. (Pubitemid 40991842)
42. Martin JA, Hamilton BE, Sutton PD, et al. Births: final data for 2007. Natl Vital Stat Rep 2010;58:1-85.
43. Huttly W, Rudnicka A, Wald NJ. Second-trimester prenatal screening markers for Down syndrome in women with insulin-dependent diabetes mellitus. Prenat Diagn 2004;24:804-7. (Pubitemid 39468662)
44. Gagnon A, Wilson RD, Audibert F, et al.; Society of Obstetricians and Gynaecologists of Canada Genetics Committee. Obstetrical complications associated with abnormal maternal serum markers analytes. J Obstet Gynaecol Can 2008;30:918-49.
45. Wald NJ, Kennard A, Hackshaw A, McGuire A. Antenatal screening for Down's syndrome. J Med Screen 1997;4:181-246. (Pubitemid 28270247)
46. Gould JB. The role of regional collaboratives: the California Perinatal Quality Care Collaborative model. Clin Perinatol 2010;37:71-86.
47. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;163:1723-29. (Pubitemid 32578778)
48. Walsh MC, Szefler S, Davis J, et al. Summary proceedings from the bronchopulmonary dysplasia group. Pediatrics 2006;117:S52-6. (Pubitemid 46063173)
49. Alexander GR, Himes JH, Kaufman RB, Mor J, Kogan M. A United States national reference for fetal growth. Obstet Gynecol 1996;87:163-8. (Pubitemid 26033124)